Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Mahvi

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patientsRyan D Cassaday, Paul M Sondel, David M King, et al.
The New England Journal of Medicine|February 3, 2016
National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical TrainingKarl Y Bilimoria, Jeanette W Chung, Larry V Hedges, et al.
Science Translational Medicine|December 18, 2012
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancerNichole R Blatner, Mary F Mulcahy, Kristen L Dennis, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2007
A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patientsRyan D Cassaday, Paul M Sondel, David M King, et al.
The New England Journal of Medicine|February 3, 2016
National Cluster-Randomized Trial of Duty-Hour Flexibility in Surgical TrainingKarl Y Bilimoria, Jeanette W Chung, Larry V Hedges, et al.
Science Translational Medicine|December 18, 2012
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancerNichole R Blatner, Mary F Mulcahy, Kristen L Dennis, et al.
Pageof 7